Back to News
Market Impact: 0.2
Disc Medicine Consensus Price Target Increased by 12.67% to $118.56
Source: Nasdaq
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
The average one-year analyst price target for Disc Medicine was revised up 12.67% to $118.56 per share from $105.23, based on Fintel's aggregate of analyst targets. The prior estimate was dated September 29, 2026.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
IRON0.40
More News
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- SpaceX bear flips to big bull because of AI business. Analyst now sees 70% gain
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- Williams Trading cuts Deckers Outdoor stock price target on weak DTC trends
- Investing.com’s stocks of the week